Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia.
about
Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: treatment options and special considerations.Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia.Argatroban in short-term percutaneous ventricular assist subsequent to heparin-induced thrombocytopenia.Current concepts review: heparin-induced thrombocytopenia.Evaluation of a clinical scoring scale to direct early appropriate therapy in heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: present and future.Argatroban therapy in pediatric patients requiring nonheparin anticoagulation: an open-label, safety, efficacy, and pharmacokinetic study.Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.The Pharmacotherapy of Heparin-Induced Thrombocytopenia (HIT) : A Review of Contemporary Therapeutic Challenges in Clinical Practice.Bleeding risk factors associated with argatroban therapy in the critically ill.Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: second edition.Novel diagnostic assays for heparin-induced thrombocytopeniaUpdate on argatroban for the prophylaxis and treatment of heparin-induced thrombocytopenia type IIPlatelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality.Pitfalls in the diagnosis of heparin-Induced thrombocytopenia: A 6-year experience from a reference laboratory.Challenging diagnosis and treatment of HIT in child with ventricular assistance device.Current management of heparin-induced thrombocytopenia.Inappropriate documentation of heparin allergy in the medical record because of misdiagnosis of heparin-induced thrombocytopenia: frequency and consequences.Immobilization and high platelet count are associated with thromboembolic complications in heparin-induced thrombocytopenia.Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia.Anticoagulants: A Review of the Pharmacology, Dosing, and Complications.Superficial vein thrombosis.Recurrent heparin-induced thrombocytopenia due to heparin rinsing before priming the machine in a hemodialysis patient: A case report.Successful Use of Intravenous Immunoglobulin G to Treat Refractory Heparin-Induced Thrombocytopenia With Thrombosis Complicating Peripheral Blood Stem Cell Harvest.Argatroban monitoring: aPTT versus chromogenic assay.
P2860
Q33373700-D1B7D907-1BA3-4FB4-AEC9-D5FF896FE934Q33374658-262C54D2-CCB1-4B98-8961-9C00F6FA17D0Q33375376-3FF07F52-7B3B-40F9-9893-D257DF24C92EQ33380780-9978638F-F35E-4D0A-9F30-4DA344855CE5Q33382108-BC861800-7531-4C0D-9668-12D40ECA1A48Q33385898-92A41D51-FA4A-4110-BEE0-D55E98AE6175Q33394188-B600AB74-5786-4C1F-A9DA-36EEA7E6490DQ33394891-9F69FF69-5036-45F4-BA15-3B032A015BA0Q33399580-6E1C2479-A53C-4FCC-B6B7-BED047E225CAQ33401236-F4C0728F-C5C0-4D0F-8B58-4DCADA93A3ADQ33402036-74528CE3-347B-469E-837A-A0DBE5A37F00Q33403703-5111D072-EB37-4023-96F7-B65575F751C9Q33406133-072AD025-E9EC-47D2-A67A-443B4A9FB85BQ33417258-28C43937-9733-49DA-A6D0-5B574A9C9ED5Q33419774-1EDC97A5-555C-462F-B5F2-E04C3244F605Q33421456-DA4239EE-3678-4B8C-B0FB-26BB970736D5Q33423746-82EAA68E-207C-4803-81E9-E780DCCC2753Q33425840-F0A22943-136A-4293-9434-5C7482280B02Q33437858-3BC3F514-A219-43EB-BC56-8F8D55F34F09Q33442116-5AE451A9-2DA8-41EA-BE60-92FF7B01D3DDQ33442746-556FA57D-C6B1-444D-A5BD-ED6214165377Q38107945-C8E151C9-5BEC-4CBA-9677-BFE0A90761A3Q43905870-D176E041-9480-4395-A202-843D2B216144Q47267941-B8BC119D-B718-4004-94D4-C219A31ABE80Q48102172-962CC7F5-5392-4CD4-A873-E46B112392ACQ53162773-04B27658-D866-4F48-AD53-0FFA55A75A23
P2860
Effects of argatroban therapy, demographic variables, and platelet count on thrombotic risks in heparin-induced thrombocytopenia.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Effects of argatroban therapy, ...... arin-induced thrombocytopenia.
@ast
Effects of argatroban therapy, ...... arin-induced thrombocytopenia.
@en
type
label
Effects of argatroban therapy, ...... arin-induced thrombocytopenia.
@ast
Effects of argatroban therapy, ...... arin-induced thrombocytopenia.
@en
prefLabel
Effects of argatroban therapy, ...... arin-induced thrombocytopenia.
@ast
Effects of argatroban therapy, ...... arin-induced thrombocytopenia.
@en
P2093
P356
P1433
P1476
Effects of argatroban therapy, ...... arin-induced thrombocytopenia.
@en
P2093
Bruce E Lewis
Diane E Wallis
Marcie J Hursting
Robert L Levine
P304
P356
10.1378/CHEST.129.6.1407
P407
P577
2006-06-01T00:00:00Z